11-64747034-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005609.4(PYGM):​c.2313-47T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,603,890 control chromosomes in the GnomAD database, including 13,023 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1434 hom., cov: 33)
Exomes 𝑓: 0.11 ( 11589 hom. )

Consequence

PYGM
NM_005609.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.39

Publications

9 publications found
Variant links:
Genes affected
PYGM (HGNC:9726): (glycogen phosphorylase, muscle associated) This gene encodes a muscle enzyme involved in glycogenolysis. Highly similar enzymes encoded by different genes are found in liver and brain. Mutations in this gene are associated with McArdle disease (myophosphorylase deficiency), a glycogen storage disease of muscle. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Sep 2009]
PYGM Gene-Disease associations (from GenCC):
  • glycogen storage disease V
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 11-64747034-A-G is Benign according to our data. Variant chr11-64747034-A-G is described in ClinVar as Benign. ClinVar VariationId is 259834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.371 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005609.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PYGM
NM_005609.4
MANE Select
c.2313-47T>C
intron
N/ANP_005600.1
PYGM
NM_001164716.1
c.2049-47T>C
intron
N/ANP_001158188.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PYGM
ENST00000164139.4
TSL:1 MANE Select
c.2313-47T>C
intron
N/AENSP00000164139.3
PYGM
ENST00000377432.7
TSL:2
c.2049-47T>C
intron
N/AENSP00000366650.3
PYGM
ENST00000483742.1
TSL:2
n.1666-47T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.116
AC:
17602
AN:
152054
Hom.:
1431
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0797
Gnomad AMI
AF:
0.0264
Gnomad AMR
AF:
0.229
Gnomad ASJ
AF:
0.130
Gnomad EAS
AF:
0.384
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.110
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0903
Gnomad OTH
AF:
0.114
GnomAD2 exomes
AF:
0.147
AC:
36787
AN:
250096
AF XY:
0.141
show subpopulations
Gnomad AFR exome
AF:
0.0782
Gnomad AMR exome
AF:
0.292
Gnomad ASJ exome
AF:
0.123
Gnomad EAS exome
AF:
0.385
Gnomad FIN exome
AF:
0.114
Gnomad NFE exome
AF:
0.0847
Gnomad OTH exome
AF:
0.120
GnomAD4 exome
AF:
0.106
AC:
154598
AN:
1451718
Hom.:
11589
Cov.:
30
AF XY:
0.107
AC XY:
77601
AN XY:
722990
show subpopulations
African (AFR)
AF:
0.0760
AC:
2524
AN:
33222
American (AMR)
AF:
0.291
AC:
12989
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
3247
AN:
26072
East Asian (EAS)
AF:
0.403
AC:
15977
AN:
39648
South Asian (SAS)
AF:
0.153
AC:
13175
AN:
85992
European-Finnish (FIN)
AF:
0.110
AC:
5887
AN:
53398
Middle Eastern (MID)
AF:
0.0752
AC:
432
AN:
5744
European-Non Finnish (NFE)
AF:
0.0849
AC:
93620
AN:
1103000
Other (OTH)
AF:
0.112
AC:
6747
AN:
60040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
8503
17005
25508
34010
42513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3734
7468
11202
14936
18670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.116
AC:
17630
AN:
152172
Hom.:
1434
Cov.:
33
AF XY:
0.122
AC XY:
9089
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0798
AC:
3314
AN:
41518
American (AMR)
AF:
0.229
AC:
3500
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.130
AC:
450
AN:
3470
East Asian (EAS)
AF:
0.385
AC:
1989
AN:
5170
South Asian (SAS)
AF:
0.163
AC:
785
AN:
4818
European-Finnish (FIN)
AF:
0.110
AC:
1161
AN:
10588
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0903
AC:
6141
AN:
68006
Other (OTH)
AF:
0.117
AC:
248
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
752
1504
2257
3009
3761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.101
Hom.:
949
Bravo
AF:
0.125
Asia WGS
AF:
0.263
AC:
915
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glycogen storage disease, type V Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.4
DANN
Benign
0.26
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs569602; hg19: chr11-64514506; COSMIC: COSV51218014; COSMIC: COSV51218014; API